| Q92478240 | Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition |
| Q99634737 | Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching |
| Q49592876 | Advances in Radiotherapy for Glioblastoma |
| Q39630347 | Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell lines |
| Q26823670 | Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy? |
| Q37665033 | Can the therapeutic gain of radiotherapy be increased by concurrent administration of Asian botanicals? |
| Q39155549 | Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line. |
| Q33816412 | Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer |
| Q33952083 | Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer |
| Q34031281 | Clinical and scientific impact of human papillomavirus on head and neck cancer |
| Q89027169 | Combination Treatment of Stereotactic Body Radiation Therapy and Immature Dendritic Cell Vaccination for Augmentation of Local and Systemic Effects |
| Q27021428 | Combining radiotherapy and cancer immunotherapy: a paradigm shift |
| Q53527650 | Comparison of Effects Between Central and Peripheral Stage I Lung Cancer Using Image-Guided Stereotactic Body Radiotherapy via Helical Tomotherapy. |
| Q38174090 | Current and emerging strategies to increase the efficacy of ionizing radiation in the treatment of cancer |
| Q35916968 | Defining the critical hurdles in cancer immunotherapy |
| Q35061159 | Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer |
| Q90047867 | Development and Radiation Response Assessment in A Novel Syngeneic Mouse Model of Tongue Cancer: 2D Culture, 3D Organoids and Orthotopic Allografts |
| Q38852405 | Endometrial cancer: Not your grandmother's cancer |
| Q92288309 | Enhancing Career Paths for Tomorrow's Radiation Oncologists |
| Q37531720 | Enhancing immune responses to tumor-associated antigens |
| Q37351567 | Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody |
| Q58609492 | Harnessing the immune system in glioblastoma |
| Q26765459 | Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium |
| Q38170122 | Immune modulation and stereotactic radiation: improving local and abscopal responses. |
| Q55322253 | Immunotherapy after chemoradiotherapy in stage III non-small cell lung cancer: a new standard of care? |
| Q38543250 | In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment |
| Q58793793 | Inhibiting the CD8 T cell infiltration in the tumor microenvironment after radiotherapy is an important mechanism of radioresistance |
| Q35052534 | Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR) |
| Q39569395 | Intratumoral injection of interleukin-2 augments the local and abscopal effects of radiotherapy in murine rectal cancer |
| Q39894616 | Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade |
| Q37693239 | Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury |
| Q64943265 | Key mechanisms involved in ionizing radiation-induced systemic effects. A current review. |
| Q33834316 | Laboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer |
| Q38210491 | Linking the history of radiation biology to the hallmarks of cancer. |
| Q37718259 | Links between innate immunity and normal tissue radiobiology |
| Q37131386 | Local control by radiotherapy: is that all there is? |
| Q30252081 | Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we? |
| Q34989668 | Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer. |
| Q36126009 | Molecular targets for tumor radiosensitization |
| Q33583931 | Multidisciplinary team approach for the management of patients with locally advanced non-small cell lung cancer: searching the evidence to guide the decision |
| Q64086368 | Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer |
| Q47580220 | Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model. |
| Q36347177 | Radiation as an immunological adjuvant: current evidence on dose and fractionation. |
| Q26865395 | Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored |
| Q36983211 | Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. |
| Q38590722 | Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer |
| Q34278609 | Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response. |
| Q37346893 | Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer |
| Q37040400 | Radiotherapy enhances antitumor effect of anti-CD137 therapy in a mouse Glioma model |
| Q38773196 | Radiotherapy in patients with connective tissue diseases. |
| Q90811958 | Radiothérapie et immunothérapie |
| Q36186619 | Role of T lymphocytes in tumor response to radiotherapy |
| Q57826816 | Stereotactic Body Radiation Therapy for Spinal Malignancies |
| Q36326713 | Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges |
| Q34082067 | Targeting immune suppressing myeloid-derived suppressor cells in oncology. |
| Q38255481 | The future of glioblastoma therapy: synergism of standard of care and immunotherapy |
| Q33802647 | Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation |
| Q28672938 | Variant splicing and influence of ionizing radiation on human endogenous retrovirus K (HERV-K) transcripts in cancer cell lines |